Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial
NCT07474090 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2026-03-16
Summary
This clinical trial studies whether a healthy living intervention (HLI), with or without a physical activity intervention (PAI), helps maintain the ability to exercise, heart health, and quality of life in breast cancer patients who are scheduled to receive chemotherapy treatment. Early detection and enhanced therapies for breast cancer have improved 5-year cancer-related survival rates. Unfortunately, many breast cancer survivors are at high risk for long-term exercise intolerance, decreased heart health, and lower quality of life following chemotherapy. Currently, there are no effective therapies to help patients maintain these areas throughout chemotherapy. The HLI in this study includes virtual health education classes, which provide useful information on topics like proper nutrition, managing stress, and sleep practices. This may help patients understand the importance of living a healthy lifestyle during chemotherapy. The PAI in this study consists of virtual exercise sessions personalized to the needs of the patient, which may make it easier for patients to stay active during chemotherapy. HLI with PAI may be a more effective way to help maintain ability to exercise, heart health, and quality of life in breast cancer patients who are scheduled to receive chemotherapy treatment.
Conditions
- Anatomic Stage I Breast Cancer AJCC v8
- Anatomic Stage II Breast Cancer AJCC v8
- Anatomic Stage III Breast Cancer AJCC v8
- Breast Carcinoma
- Breast Inflammatory Carcinoma
- Locally Recurrent Breast Carcinoma
Interventions
- OTHER
-
Exercise Intervention
Attend virtual personalized exercise sessions
- OTHER
-
Educational Intervention
Attend organized health workshops
- OTHER
-
Supportive Care
Receive Fitbit device, resistance bands, and/or loaner tablet
- PROCEDURE
-
Biospecimen Collection
Undergo blood sample collection
- PROCEDURE
-
Magnetic Resonance Imaging
Undergo CMR
- PROCEDURE
-
Magnetic Resonance Imaging
Undergo ExeCMR
- OTHER
-
Questionnaire Administration
Ancillary studies
- PROCEDURE
-
Accelerometry
Ancillary Studies
- OTHER
-
Electronic Health Record Review
Ancillary Studies
- OTHER
-
Cardiopulmonary Exercise Testing
Undergo CPET
Sponsors & Collaborators
-
Wake Forest University Health Sciences
lead OTHER
Principal Investigators
-
Glenn Lesser, MD · Wake Forest University Health Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-07-05
- Primary Completion
- 2029-09-01
- Completion
- 2030-01-31
More Related Trials
-
High-Intensity Interval Training for Stage I-III Breast Cancer Patients
NCT02454777 ·Status: TERMINATED ·Phase: NA
-
Exercise for Ameliorating Chemotherapy Cardiotoxicity
NCT06595316 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Acute Exercise Cardioprotection From Doxorubicin
NCT02006979 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity
NCT05036252 ·Status: ACTIVE_NOT_RECRUITING
-
Neoadjuvant Chemotherapy of Primary Breast Cancer With Epirubicin/Docetaxel and Carboplatin/Docetaxel
NCT00527449 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer.
NCT03027063 ·Status: COMPLETED ·Phase: NA
-
Strive Cardio for Endometrial Cancer Survivors
NCT06534008 ·Status: COMPLETED ·Phase: NA
-
HeartPhone Cancer Survivors Trial 2019
NCT03953326 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Caloric Restriction and Exercise for Protection From Anthracycline Toxic Effects
NCT03131024 ·Status: COMPLETED ·Phase: NA
-
Exercise and Tumor Blood Flow in Breast Cancer Patients
NCT04416087 ·Status: UNKNOWN ·Phase: NA
-
Feasibility of Lifestyle Intervention in BRCA1/2 Mutation Carriers
NCT02087592 ·Status: COMPLETED ·Phase: NA
-
STOP Heart Disease in Breast Cancer Survivors Trial
NCT02674204 ·Status: TERMINATED ·Phase: PHASE2
-
EXercise Influence on Taxane Side Effects (EXIT) Study
NCT02473861 ·Status: COMPLETED ·Phase: NA
-
A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants With Breast Cancer and Solid Tumors
NCT05262400 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice
NCT04297384 ·Status: COMPLETED ·Phase: NA
-
Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning
NCT07023887 ·Status: RECRUITING
-
Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2)
NCT03748550 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cardiotoxicity Assessment and Reduction Through Exercise in BREAST Cancer
NCT07405385 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery
NCT01147016 ·Status: TERMINATED ·Phase: PHASE2
-
Cardioprotective Effect of Acute Exercise in Breast Cancer Patients
NCT05467111 ·Status: RECRUITING ·Phase: NA
-
Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer
NCT00005970 ·Status: COMPLETED ·Phase: PHASE3
-
Survival TRaining for ENhancing Total Health (STRENGTH)
NCT00068458 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Exercise on Quality of Life of EBC Patients on Treatment With Adjuvant AI With or Without CDK4/6 Inhibitors
NCT07215364 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer
NCT00005800 ·Status: COMPLETED ·Phase: PHASE2
-
Investigating Paclitaxel Toxicity in Breast Cancer: the Roles of Physical Activity and Body Composition.
NCT06387901 ·Status: RECRUITING